Anastrozole (Page 8 of 8)

Package/Label Display Panel

Anastrozole Tablets, 1mg, 30 Tablets

NDC 68001-155-04

Anastrozole Tablets USP 1 mg 30ct Rev 1219
(click image for full-size original)
ANASTROZOLE anastrozole tablet, coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68001-155
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ANASTROZOLE (ANASTROZOLE) ANASTROZOLE 1 mg
Inactive Ingredients
Ingredient Name Strength
HYPROMELLOSE, UNSPECIFIED
LACTOSE, UNSPECIFIED FORM
MAGNESIUM STEARATE
POLYETHYLENE GLYCOL, UNSPECIFIED
SODIUM STARCH GLYCOLATE TYPE A POTATO
POVIDONE, UNSPECIFIED
TITANIUM DIOXIDE
Product Characteristics
Color WHITE (WHITE) Score no score
Shape ROUND (ROUND) Size 6mm
Flavor Imprint Code A7
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68001-155-04 30 TABLET, COATED in 1 BOTTLE None
2 NDC:68001-155-08 1000 TABLET, COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078921 01/01/2014
Labeler — BluePoint Laboratories (985523874)
Registrant — Zydus Pharmaceuticals (USA) Inc. (156861945)
Establishment
Name Address ID/FEI Operations
Cadila Healthcare Limited 918596198 ANALYSIS (68001-155), MANUFACTURE (68001-155)

Revised: 01/2020 BluePoint Laboratories

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2020. All Rights Reserved.